MedTrace Logo

Clinical Trial to Evaluate the Influence of Genotype and DDIs of Aspirin on the PK/PD of Clopidogrel and PK of Digoxin

NCT01775839 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2014-06-10

No results posted yet for this study

Summary

Clinical trial to evaluate the influence of multiple aspirin administration on PK and PD of co-administered drugs

Conditions

  • DRUG REACTIONS

Interventions

DRUG

Aspirin+Clopidogrel/Digoxin(oral)

oral administration of digoxin

DRUG

Aspirin+Clopidogrel/Digoxin(IV)

intravenous administration of digoxin

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • In-Jin Jang, MD · SNUH

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01775839 on ClinicalTrials.gov